Russia's sovereign wealth fund has filed for registration of Sputnik V in the European Union and expects it to be reviewed in February, the official account promoting the COVID-19 vaccine tweeted on Wednesday.
The Sputnik V and European Medical Agency (EMA) teams held a scientific review of the vaccine on Tuesday, the Sputnik V account said, adding the EMA will take a decision on the authorization of the vaccine based on the reviews. (https://bit.ly/39OQZDR)
The vaccine has already been approved in Argentina, Belarus, Serbia and other countries.


Trump says US destroyed mine-laying vessels after warning Iran
Britain working with allies to support shipping through Strait of Hormuz
Five Iranian women's soccer players granted humanitarian visas in Australia
Almost 700,000 displaced after Israeli strikes on Lebanon, UN agencies say
